Clinical Trials Logo

Clinical Trial Summary

This study is designed to explore lung function effects of two doses of indacaterol acetate, 75 μg and 150 μg, in pediatric asthma patients 6-11 years old, and to compare the systemic exposure to indacaterol in plasma with historical data in adults, to identify an appropriate dose to Phase III evaluation.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT02892019
Study type Interventional
Source Novartis
Contact Novartis Pharmaceuticals
Phone +41613241111
Status Recruiting
Phase Phase 2
Start date April 18, 2017
Completion date May 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT03086460 - A Dose Ranging Study of CHF 1531 in Asthmatic Subjects Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Recruiting NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Active, not recruiting NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Completed NCT01318980 - A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A Phase 1
Recruiting NCT02782065 - Validation of the Hospital Asthma Severity Score (HASS)
Withdrawn NCT02546869 - A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting Phase 3
Completed NCT02449473 - Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids Phase 2
Completed NCT02501629 - An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils Phase 3
Completed NCT01691859 - MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects Phase 3
Completed NCT01687283 - Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma Phase 3
Completed NCT00446056 - Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379) Phase 4
Recruiting NCT03691961 - Corticosteroids/β2-agonists in Hair in Asthmatic Patients (CorticHair) N/A
Completed NCT00972673 - A Study of GW685698X in Healthy Japanese Male Subjects Phase 1
Withdrawn NCT02794519 - A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma Phase 2
Recruiting NCT03528577 - A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited) Phase 3